0.63 (1.17%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Neutral
Earnings
Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Strong
Website
Xenon Pharmaceuticals Inc.
Telephone
1.604.484.3300
Address
200-3650 Gilmore Way, Burnaby, BC V5G 4W8
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 28.19 - 63.95
Trade Value (12mth)
US$11,398,812.00
1 week
-0.63%
1 month
-4.17%
YTD
21.49%
1 year
77.45%
All time high
63.95
EPS 3 yr Growth
111.50%
EBITDA Margin
NaN%
Operating Cashflow
-$279m
Free Cash Flow Return
-41.30%
ROIC
-51.20%
Interest Coverage
0.00
Quick Ratio
13.40
Shares Outstanding (Fully Diluted)
87m
HALO Sector
Healthcare
Next Company Report Date
04-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 08 May 26 | |
| 08 May 26 | |
| 08 May 26 | |
| 08 May 26 | |
| 14 April 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -2.73 | -3.01 | -4.36 | | | | ||
EPS (Fully Diluted) | $ | | | | | -2.73 | -3.01 | -4.36 | | | | ||
Growth | % | | | | | -32.1 | -10.3 | -45.1 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
